Data recently released from Prostate Cancer UK demonstrates that prostate cancer has become the third most common cause of cancer death in the UK, overtaking breast cancer.
Browsing: Disease Area > Prostate
Researchers have discovered that a shorter course of radiation using higher doses over fewer days may be a more effective approach for some men with intermediate-risk prostate cancer.
Prostate cancer screening and detection remain challenging issues, with changes in recommendations for prostate-specific antigen testing causing a significant change in approach. In this editorial discover the multiple roles and applications of prostate MRI.
Discover the promises and limitations of peptide-based vaccines for the treatment of prostate cancer, in this commentary article from Future Science OA
This review discusses the key sequences that comprise a mpMRI exam of the prostate gland including technical factors that affect image quality, such as pre-exam patient preparation, magnet field strength, endorectal coil utilization and sequence parameters.
Experts warn that recent legislative proposals may endanger research on the environment and cancer, following a study highlighting the positive association between cancer incidence and poor environment quality.
Discover the potential role for prostate multiparametric MRI and targeted biopsy techniques incorporating MRI into active surveillance in this article from Future Oncology.
To mark World Health Day, for which the theme this year is depression, Oncology Central spoke with Christopher Sharpley about his research into uncovering novel treatments for depression in prostate cancer patients and his hopes for the future of the field.